Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AIM Vaccine / 艾美疫苗

Request full access

Beijing HK-listed full-chain human vaccine group (HKEX 06660)

ChinaFounded 2011Biotech & Life Sciences

About AIM Vaccine / 艾美疫苗

Beijing HK-listed full-chain human vaccine group (AIM Vaccine / 艾美疫苗; HKEX 06660) — recombinant HBV, Vero rabies, HAV, mumps, HFRS and MPSV4 plus mRNA / PCV pipeline across multiple licensed manufacturing subsidiaries — mid-size China vaccine leftover beyond Biokangtai FIX / Pack 41 CanSinoBIO FIX / Walvax mega soft-skip. The company covers R&D through manufacturing and commercialization for human vaccines serving provincial and municipal immunization programs across China.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2011
Headquarters
China
Listing
IPO 2022
Sector
Biotech & Life Sciences
Outcome tier
Thoroughbred$100M+ revenue

AIM Vaccine / 艾美疫苗 in its local ecosystem

Live from Dealroom

The AIM Vaccine / 艾美疫苗 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown
Web traffic by country
15K monthly visits
across markets
🇺🇸 United States17.3%
🇨🇦 Canada7.3%
🇮🇳 India4.7%
Top 3 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AIM Vaccine / 艾美疫苗 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AIM Vaccine / 艾美疫苗 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.